Iden Biotechnology and the J.R. Simplot Company have recently entered into an agreement to explore the potential for nutritional enrichment in the potato. As part of the agreement, Iden will identify promising genes for potential use in Simplot’s proprietary Innate biotechnology platform. 

Iden will use its identification and screening platform for the development of gene traits of agronomic relevance for main crops like corn, wheat or potato for specific validation of gene candidates meeting Simplot company interests. Iden has established other industrial collaborations for gene trait discovery and development in row crops like wheat and corn.

“We are very pleased to partner with Simplot, a global agribusiness leader, on biotechnological products in potato that bring innovation and value to the farmers,” said Nora Alonso, CEO of Iden. 

The agreement allows Simplot to further develop traits in its Innate platform that benefit growers and consumers in the industry.

“Iden Biotechnology is a recognized leader in gene trait discovery and we’re excited to be working with them to uncover new possibilities to improve the potato,” said Dr. Susan Collinge, Vice President of Simplot Plant Sciences. 

Related articles: 

Simplot Postpones the Introduction of Innate Potatoes in Canada 

Simplot Starts Construction of New Plant in Mendoza, Argentina 

Simplot’s First Generation of Innate Potatoes Receives Canadian Government Clearance